2021-01-07,Dr David Stamler Appointed CEO
2020-12-21,Alterity and UniQuest partner to reverse bacterial resistance to antibiotics
2020-12-09,Is Alterity Therapeutics (ASX:ATH) In A Good Position To Deliver On Growth Plans?
2020-11-16,Alterity Therapeutics stock more than doubles on massive volume after new patent announcement
2020-11-16,Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases
2020-10-26,Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study
2020-08-05,Why Alterity's Stock Is Trading Lower Today
2020-08-04,"Alterity's stock nearly triples on heavy volume after update on study of treatment for MSA, Parkinson's"
2020-08-04,Alterity Therapeutics Shares Surge As Company Says Animal Testing Data Positive For MSA Drug
2020-08-03,New data independently confirms and extends laboratory findings and expands safety profile of ATH434
2020-07-30,Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report
2020-07-01,"The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes"
2020-06-29,Alterity Therapeutics meeting with US FDA provides development pathway for ATH434
2020-05-20,Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology
2020-04-30,Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report
2020-04-21,How Should Investors React To Alterity Therapeutics Limited's (ASX:ATH) CEO Pay?
2020-02-21,Imagine Owning Alterity Therapeutics (ASX:ATH) And Trying To Stomach The 86% Share Price Drop
2019-11-11,Companies Like Alterity Therapeutics (ASX:ATH) Can Be Considered Quite Risky
2019-09-12,Does Alterity Therapeutics Limited's (ASX:ATH) CEO Salary Reflect Performance?
2019-07-29,Alterity Therapeutics Announces Successful Completion of Phase 1 Clinical Trial
2019-07-11,Imagine Owning Alterity Therapeutics (ASX:ATH) And Trying To Stomach The 89% Share Price Drop
2019-05-06,Initial Data for Alterity Therapeutics Phase 1 Clinical Trial Released at American Academy of Neurology Annual Meeting
2019-05-03,Alterity Therapeutics Presents at the American Academy of Neurology Annual Meeting
